Suzhou Zelgen Biopharmaceuticals Co.,ltd

This study tests an oral medication called jaktinib for adults with moderate to severe atopic dermatitis (eczema). About 443 participants will receive either jaktinib or a placebo to see if it improves skin symptoms like redness and itching. The goal is to reduce eczema severity …

This study tests a new drug called jaktinib in 265 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants receive either jaktinib or a placebo to see if the drug improves symptoms like pain and movement. The main goal is t…

This study tests a new drug called ZG005 in 50 adults with advanced solid tumors that did not respond to or could not tolerate standard treatments. The main goal is to see if the drug shrinks tumors and to check for side effects. Participants receive the drug and are monitored cl…